title: Spontaneous antibody-secreting cells in the stomach of gastric cancer patients.
abstract: The gastric mucosa has been regarded as an active site of humoral immunity since the discovery of Helicobacter pylori. The present study was conducted to determine the in vivo activity of gastric B cells in 53 gastric cancer patients. B-cell activity was measured by protein-A plaque assay, in which IgA-, IgM-, and IgG-plaque-forming cells (PFC) were counted. The number of PFC was associated with the stage of cancer, but the response of lymphocytes in a non-tumorous area (NML) and tumor-infiltrating lymphocytes (TIL) differed. PFC in both sites were decreased compared to n0 cancer in n1 lymph node metastasis-positive cancer, while only NML showed raised PFC in n2 + (P < 0.05, vs TIL). Cancer cells penetrating the submucosa caused the PFC of TIL (but not of NML) to decrease. Invasion of the intratumor capillary (V) or lymphatic (Ly) vessels also caused PFC to change, showing differences of Ig class; there was a decrease of PFC in V2 (IgG- and IgM-PFC) and in Ly2 (all Ig-PFC). IgA-PFC in Ly1 differed in TIL (decrease of PFC) and NML (increase). PFC also differed in TIL and NML in cancer cells, as follows: TIL < NML in tubular and poorly differentiated adenocarcinoma and TIL > NML in papillary and signet ring cell adenocarcinoma. Changes in lymph node (LNL) and blood lymphocytes were similar to those in gastric PFC whose IgA value was 10 times as much as that of LNL. The 5-year survival rate was significantly better in patients with lower rather than higher PFC such as 89% vs 68%. Gastric B cells thus appear to be active and to reflect gastric mucosal immunity.
authors.affiliation: Department of Surgery, Iwaki-Kyoritsu Hospital, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kunori
authors.forename: F
authors.initials: F
authors.lastname: Shinya
authors.forename: T
authors.initials: T
authors.lastname: Satomi
authors.forename: J
authors.initials: J
authors.lastname: Itoh
authors.forename: M
authors.initials: M
authors.lastname: Abe
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: T
authors.initials: T
authors.lastname: Yokota
authors.forename: Y
authors.initials: Y
authors.lastname: Abe
authors.forename: K
authors.initials: K
authors.lastname: Hiraoka
authors.forename: S
authors.initials: S
authors.lastname: Kawaguchi
authors.forename: I
authors.initials: I
authors.lastname: Tanaka
authors.forename: M
authors.initials: M
authors.lastname: Mochizuki
authors.forename: S
authors.initials: S
authors.lastname: Asano
mesh_terms: D000328:Adult; D000368:Aged; D000912:Antibodies, Neoplasm / Q000378:metabolism*; D000921:Antibody-Producing Cells / Q000378:metabolism*; D001402:B-Lymphocytes / Q000378:metabolism; D005260:Female; D005753:Gastric Mucosa / Q000276:immunology* / Q000473:pathology; D006462:Hemolytic Plaque Technique; D006801:Humans; D018928:Immunity, Mucosal; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012680:Sensitivity and Specificity; D013274:Stomach Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
chemical_list: D000912:Antibodies, Neoplasm